Bleomycin, vinorelbine and trofosfamide in relapsed stage IV cutaneous malignant melanoma patients

Cancer Chemotherapy and Pharmacology

Volumn 64, Issue 5, 2009, Pages 901-905

  Atzpodien, Jens ^a   Morawek, Lars ^a   Fluck, Michael ^a   Reitz, Martina ^b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b Europaisches Institut fur Tumor Immunologie und Pravention EUTIP   (Germany)

Author keywords

Bleomycin, vinorelbine, and trofosfamide; Melanoma

Indexed keywords

BLEOMYCIN; CARMUSTINE; CISPLATIN; DACARBAZINE; FOTEMUSTINE; GEMCITABINE; NAVELBINE; RECOMBINANT ALPHA2A INTERFERON; TREOSULFAN; TROFOSFAMIDE; VINBLASTINE;

ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER GROWTH; CANCER PATIENT; CANCER REGRESSION; CANCER RELAPSE; CANCER STAGING; CLINICAL ARTICLE; DEATH; DRUG EFFICACY; DRUG TOLERABILITY; FATIGUE; FEMALE; HUMAN; LEUKOPENIA; MALE; MELANOMA; MULTIPLE CYCLE TREATMENT; NAUSEA; OVERALL SURVIVAL; PAIN; PRIORITY JOURNAL; SIDE EFFECT; SURVIVAL RATE; TREATMENT RESPONSE; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; KARNOFSKY PERFORMANCE STATUS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; SKIN NEOPLASMS; SURVIVAL ANALYSIS; VINBLASTINE;

EID: 69049109768     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-009-0939-3     Document Type: Article

References (19)

1. MS Vuoristo M Hahka-Kemppinen LM Parvinen S Pyrhönen H Seppä M Korpela P Kellokumpu-Lehtinen 2005 Randomized trial of dacarbazine versus bleomycin, vincristine, lomustine and dacarbazine (BOLD) chemotherapy combined with natural or recombinant interferon-alpha in patients with advanced melanoma Melanoma Res 15 4 291 296
2. MB Lens TG Eisen 2003 Systemic chemotherapy in the treatment of malignant melanoma Expert Opin Pharmacother 4 12 2205 2211
3. J Atzpodien K Neuber D Kamanabrou M Fluck EB Brocker C Neumann TM Runger G Schuler P von den Driesch I Muller E Paul T Patzelt M Reitz 2002 Combination chemotherapy with or without s.c. IL2 and IFN-alpha: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (ACIMM) Br J Cancer 86 2 179 184
4. ME Stein Z Bernstein M Tsalic K Drumea M Steiner Z Sklar N Haim 2002 Chemoimmunohormonal therapy with carmustine, dacarbazine, cisplatin, tamoxifen, and interferon for metastatic melanoma: a prospective phase II study Am J Clin Oncol 25 5 460 463
5. CJ Punt CM van Herpen RL Jansen G Vreugdenhil EW Muller PH de Mulder 1997 Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II study Br J Cancer 76 2 266 269
6. L Serrone M Zeuli FM Sega F Cognetti 2000 Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview J Exp Clin Cancer Res 19 1 21 34
7. AG Polischouk A Holgersson D Zong B Stenerlöw HL Karlsson L Möller K Viktorsson R Lewensohn 2007 The antipsychotic drug trifluoperazine inhibits DNA repair and sensitizes non small cell lung carcinoma cells to DNA double-strand break induced cell death Mol Cancer Ther 6 8 2303 2309
8. A Photiou MN Sheik D bafaloukos S Retsas 1992 Antiproliferative activity of vinrelbine (Navelbine) against six human melanoma cell lines J Cancer Res Clin Oncol 118 249 254
9. A Photiou P Shah LK Leong J Moss S Retsas 1997 In vitro synergy of paclitaxel (Taxol) and vinorelbine (navelbine) against human melanoma cell lines Eur J Cancer 33 3 463 470
10. HA Burris III S Fields 1994 Summary of data from in vitro and phase I vinorelbine (navelbine) studies Semin Oncol 21 5 Suppl 10 14 19
11. RP Whitehead J Moon SS McCachren EM Hersh WE Samlowski JT Beck NS Tchekmedyian VK Sondak Southwest Oncology Group 2004 A phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study Cancer 100 8 1699 1704
12. LG Feun N Savaraj J Hurley A Marini S Lai 2000 A clinical trial of intravenous vinrorelbine tartrate plus tamoxifen in the treatment of patients with advanced malignant melanoma Cancer 88 3 584 588
13. H Gogas D Bafaloukos G Aravantinos G Fountzilas D Tsoutsos P Panagiotou K Frangia HP Kalofonos E Briasoulis O Castana A Polyzos D Pectasides J Ioannovich Hellenic Cooperative Oncology Group 2004 Vinorelbine in combination with interleukin-2 as second-line treatment in patients with metastatic melanoma. A phase II study of the Hellenic Cooperative Oncology Group Cancer Invest 22 6 832 839
14. JP Fruehauf KM Kong JG Jakowatz 2005 Docetaxel and vinorelbine plus GM-CSF in malignant melanoma Oncology 19 4 Suppl 2 19 22
15. D Latz N Nassar R Frank 2004 Trofosfamide in the palliative treatment of cancer: a review of the literature Onkologie 27 6 572 576
16. E Salminen V Nikkanen L Lindholm 1997 Palliative chemotherapy in non-Hodgkin's lymphoma Oncology 54 2 108 111
17. A Reichle K Bross T Vogt F Bataille P Wild A Berand SW Krause R Andreesen 2004 Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far-advanced melanoma and soft tissue sarcoma Cancer 101 10 2247 2256
18. AH Enk J Knop 2000 Stabilizing the course of patients with stage IV advanced malignant melanoma by trofosfamide treatment Hautarzt 51 7 486 489
19. PB Chapman LH Einhorn ML Meyers S Saxman AN Destro KS Panagea CB Begg SS Agarwala LM Schuchter MS Ernstoff AN houghton JM Kirkwood 1999 Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma J Clin Oncol 17 9 2745 2751